Skip to main content
TRANS INDIA HOUSE IMPEX LIMITED logo

TRANS INDIA HOUSE IMPEX LIMITED — Investor Relations & Filings

Ticker · 523752 ISIN · INE502D01011 LEI · 9845004BED7F14CI8B19 BSE.NS Wholesale and retail trade
Open in API
Filings indexed 5 across all filing types
Latest filing 2026-05-27 Report Publication Anno…
Country IN India
Listing BSE.NS 523752

About TRANS INDIA HOUSE IMPEX LIMITED

https://tihil.co.in/

Trans India House Impex Limited specializes in the international trading and export of a diverse range of products, including textiles, ceramic tiles, and various consumer commodities. The company focuses on establishing robust supply chain solutions to bridge the gap between manufacturers and global markets. By leveraging extensive logistics networks and quality control processes, it ensures the delivery of high-standard goods to its international clientele. Its core operations revolve around sourcing, procurement, and distribution, catering to the specific requirements of diverse sectors. The firm emphasizes reliability and efficiency in its trade operations, aiming to provide value-added services through comprehensive market analysis and strategic sourcing.

Recent filings

Filing Released Lang Actions
We are submitting herewith Disclosure under Regulation 30 of SEBI(LODR) Regulation, 2015 - Copies of Newspaper Publication.
Report Publication Announcement Classification · 93% confidence The document is a stock‐exchange submission under SEBI LODR Regulations 30 and 47, notifying the BSE that the company had published its audited standalone and consolidated financial results in newspapers and enclosing the clippings. It does not itself contain the financial statements but merely announces and attaches their publication. This matches the “Report Publication Announcement (RPA)” category rather than an actual earnings release or interim report.
2026-05-27 English
Appointment of Internal Auditor for FY 2026-27.
Audit Report / Information Classification · 85% confidence The document is a formal SEBI Listing Regulations filing under Regulation 30 & 33, notifying the exchange of the Board-approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and attaching the Statutory Auditors’ Report (unmodified opinion) as well as details of an internal auditor appointment. It is not a full annual report (10-K) nor a simple earnings release or mere publication notice, but rather the standalone audit report and audited results submission. This aligns with the definition of Audit Report / Information (Code: AR). FY 2026
2026-05-26 English
Standalone and Consolidated Financial Results for the Quarter and Financial Year ended 31st March 2026.
Interim / Quarterly Report Classification · 85% confidence The document is a formal SEBI (Listing Obligations and Disclosure Requirements) Regulation 30 and 33 disclosure submitted to BSE, containing the Board meeting outcome and the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026, along with the auditor’s report and related schedules. This is not a full annual report (10-K), nor merely a highlights release (ER), but a comprehensive periodic financial results filing with substantive financial statements and audit opinion. Under our definitions, this aligns with an Interim / Quarterly Report (IR). FY 2026
2026-05-26 English
Outcome of Board Meeting dated 26th May 2026.
Interim / Quarterly Report Classification · 85% confidence The document is the formal outcome of a board meeting filed under SEBI Regulations 30 and 33, containing the Audited Standalone and Consolidated Financial Results for the quarter (Q4) and financial year ended 31 March 2026, complete with detailed financial figures and the Statutory Auditors’ report. This is more than just a summary earnings highlight (ER) and stops short of a full annual report (10-K). It constitutes a comprehensive financial report for a period shorter than a fiscal year (the quarter) though it also includes year-end data as typical for a Q4 filing. Hence it matches the definition of an Interim/Quarterly Report (IR). FY 2026
2026-05-26 English
Trans India House Impex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve 1. Audited Standalone ....
Regulatory Filings Classification · 85% confidence The document is a notice to the stock exchange of an upcoming Board meeting to consider approved audited standalone and consolidated financial results. It does not itself contain financial results or management changes, nor is it the report publication. There is no category for ‘board meeting notice,’ so this falls into the general regulatory exchange filing (“RNS”) fallback.
2026-05-13 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.